BioElectronics Corporation Announces Italian Over-the-Counter Approval From Ministry of Health for ActiPatch(TM)

FREDERICK, Md.--(BUSINESS WIRE)--BioElectronics Corp. (BIEL), the maker of ActiPatch™, the drug free anti-inflammatory patch, with an embedded battery operated microchip delivering continuous pulse therapy that revolutionizes the way people heal, today announced the company's products have received approval from the Italian Ministry of Health allowing for over-the-counter sales throughout Italy, the world's seventh biggest economy. The company’s Italian distributor has placed additional restocking orders as sales of ActiPatch have continued to grow throughout the country.